Meridian Bioscience (VIVO) 10-Q 2003 Q2 Quarterly report

      EXHIBIT 99.2

CERTIFICATION CHIEF FINANCIAL OFFICER

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing with the Securities and Exchange Commission of the Quarterly Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-Q for the quarter ending March 31, 2003 (the “Report”), I, Melissa Lueke, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Melissa Lueke

Melissa Lueke, Chief Financial Officer

May 9, 2003

Date

A signed original of this statement required by Section 906 has been provided to Meridian Bioscience, Inc. and will be retained by Meridian Bioscience, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Page 28 of 28